151 related articles for article (PubMed ID: 7758054)
1. The efficacy and safety of once-daily nifedipine: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate diastolic hypertension. Nifedipine Study Group.
Glasser SP; Jain A; Allenby KS; Shannon T; Pride K; Pettis PP; Schwartz LA; MacCarthy EP
Clin Ther; 1995; 17(1):12-29. PubMed ID: 7758054
[TBL] [Abstract][Full Text] [Related]
2. The efficacy and safety of once-daily nifedipine administered without food: the coat-core formulation compared with the gastrointestinal therapeutic system formulation in patients with mild-to-moderate hypertension. Nifedipine Study Group.
Glasser SP; Ripa SR; Allenby KS; Schwartz LA; Commins BM; Jungerwirth S
Clin Ther; 1995; 17(2):296-312. PubMed ID: 7614530
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 24-hour ambulatory blood pressure data in hypertensive patients switched from nifedipine-GITS to nifedipine-CC.
Wurdeman RL; Mooss AN; Mohiuddin SM; Lucas BD; Ryschon KL; Hilleman DE
Pharmacotherapy; 1999 Jan; 19(1):94-100. PubMed ID: 9917082
[TBL] [Abstract][Full Text] [Related]
4. Blood pressure control in patients with mild to moderate essential hypertension switched from nifedipine gastrointestinal therapeutic system (GITS) 30 mg to nifedipine GITS 20 mg.
Toal CB;
Clin Ther; 2001 Jan; 23(1):87-96. PubMed ID: 11219482
[TBL] [Abstract][Full Text] [Related]
5. Trough and peak effects of a single daily dose of nifedipine gastrointestinal therapeutic system (GITS) as assessed by ambulatory blood pressure monitoring. Italian Nifedipine GITS Study Group.
Zanchetti A
J Hypertens Suppl; 1994 Jul; 12(5):S23-7. PubMed ID: 7965282
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
[TBL] [Abstract][Full Text] [Related]
7. Nifedipine gastrointestinal therapeutic system versus nifedipine coat-core: comparison of efficacy via 24-hour ambulatory blood pressure monitoring.
Defina LF; Bookstaver DA; Goldfinger MP; Coffey TA
Ann Pharmacother; 1997; 31(7-8):819-22. PubMed ID: 9220037
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy and safety of nifedipine coat-core versus amlodipine in the treatment of patients with mild-to-moderate essential hypertension. Hypertension Study Group.
Zidek W; Spiecker C; Knaup G; Steindl L; Breuer HW
Clin Ther; 1995; 17(4):686-700. PubMed ID: 8565032
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
Fagan TC; Haggert BE; Liss C
Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension.
Weir MR; Elkins M; Liss C; Vrecenak AJ; Barr E; Edelman JM
Clin Ther; 1996; 18(3):411-28. PubMed ID: 8829017
[TBL] [Abstract][Full Text] [Related]
11. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
[TBL] [Abstract][Full Text] [Related]
12. The 24-hour efficacy of a new once-daily formulation of nifedipine. Italian Nifedipine GITS Study Group.
Zanchetti A
Drugs; 1994; 48 Suppl 1():23-30; discussion 30-1. PubMed ID: 7533703
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a low dose nifedipine GITS (20 mg) in patients with mild to moderate hypertension.
Toal CB
Can J Cardiol; 1997 Oct; 13(10):921-7. PubMed ID: 9374948
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of once-daily nifedipine coat-core in the treatment of mild-to-moderate hypertension. Adalat CC Cooperative Study Group.
Feig PU; Gibson L; Mac Carthy EP; Pettis PP; Schwartz L
Clin Ther; 1993; 15(6):963-75. PubMed ID: 8111816
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators.
Opie LH; Müller FO; Myburgh DP; Rosendorff C; Sareli P; Seedat YK; Weich DJ; Luus HG
Am J Hypertens; 1997 Mar; 10(3):250-60. PubMed ID: 9056681
[TBL] [Abstract][Full Text] [Related]
16. A randomised double-blind study comparing nifedipine GITS 20 mg and bendrofluazide 2.5 mg administered once daily in mild-to-moderate hypertension.
Isles CG; Kitchin NR
J Hum Hypertens; 1999 Jan; 13(1):69-73. PubMed ID: 9928755
[TBL] [Abstract][Full Text] [Related]
17. Comparative effects of amlodipine and nifedipine GITS during treatment and after missing two doses.
Hernández RH; Armas-Hernández MJ; Chourio JA; Armas-Padilla MC; López L; Alvarez M; Pacheco B
Blood Press Monit; 2001 Feb; 6(1):47-57. PubMed ID: 11248761
[TBL] [Abstract][Full Text] [Related]
18. Twenty-four hour ambulatory blood pressure in the International Nifedipine GITS Study Intervention as a Goal in Hypertension Treatment (INSIGHT).
Mancia G; Omboni S; Parati G;
J Hypertens; 2002 Mar; 20(3):545-53. PubMed ID: 11875324
[TBL] [Abstract][Full Text] [Related]
19. The safety and efficacy of once-daily nifedipine coat-core in combination with atenolol in hypertensive patients. Adalat CC Cooperative Study Group.
Mac Carthy EP; Pettis PP; Gibson L; Schwartz L; Feig PU
Clin Ther; 1993; 15(6):976-87. PubMed ID: 8111817
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial on the blood pressure-lowering effect of amlodipine and nifedipine-GITS in sustained hypertension.
Huang QF; Sheng CS; Li Y; Dou Y; Zheng MS; Zhu ZM; Wang JG;
J Clin Hypertens (Greenwich); 2019 May; 21(5):648-657. PubMed ID: 30973207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
